Arcus Biosciences (RCUS) Research & Development (2017 - 2026)

Arcus Biosciences' Research & Development history runs 10 years deep, the most recent figure standing at $122.0 million for Q1 2026.

• On a quarterly basis, Research & Development changed 0.0% year-over-year to $122.0 million in Q1 2026; TTM through Mar 2026 was $523.0 million, a 13.45% increase from a year earlier, with the FY2025 full-year figure at $523.0 million, up 16.74% from the prior year.
• Research & Development grew to $122.0 million in Q1 2026 per RCUS's latest filing, from $121.0 million in the prior quarter.
• Across five years, Research & Development topped out at $141.0 million in Q3 2025 and bottomed at $61.0 million in Q1 2022.
• The 5-year median for Research & Development is $101.0 million (2024), against an average of $101.2 million.
• Biggest YoY gain for Research & Development was 58.14% in 2022; the steepest drop was 8.11% in 2022.
• Year by year, Research & Development stood at $80.0 million in 2022, then climbed by 16.25% to $93.0 million in 2023, then advanced by 8.6% to $101.0 million in 2024, then climbed by 19.8% to $121.0 million in 2025, then climbed by 0.83% to $122.0 million in 2026.
• Per Business Quant, the three latest RCUS Research & Development figures stand at $122.0 million (Q1 2026), $121.0 million (Q4 2025), and $141.0 million (Q3 2025).